These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22748604)

  • 21. N-of-1 (single-patient) trials for statin-related myalgia.
    Joy TR; Monjed A; Zou GY; Hegele RA; McDonald CG; Mahon JL
    Ann Intern Med; 2014 Mar; 160(5):301-10. PubMed ID: 24737272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.
    Moutzouri E; Liberopoulos E; Mikhailidis DP; Kostapanos MS; Kei AA; Milionis H; Elisaf M
    Int J Clin Pract; 2011 Nov; 65(11):1141-8. PubMed ID: 21995692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How safe is aggressive statin therapy?
    Guthrie RM
    Prog Cardiovasc Nurs; 2006; 21(3):140-5. PubMed ID: 16957460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-of-1 (single-patient) trials for statin-related myalgia.
    Joy TR; Zou GY; Mahon JL
    Ann Intern Med; 2014 Oct; 161(7):531-2. PubMed ID: 25285548
    [No Abstract]   [Full Text] [Related]  

  • 27. N-of-1 (single-patient) trials for statin-related myalgia.
    Akinboro O; Williams L; Pomerantz D
    Ann Intern Med; 2014 Oct; 161(7):531. PubMed ID: 25285547
    [No Abstract]   [Full Text] [Related]  

  • 28. Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective.
    Montouchet C; Ruff L; Balu S
    J Med Econ; 2013 Jul; 16(7):907-16. PubMed ID: 23641809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
    Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
    Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients.
    Wehlou CM; Speeckaert MM; Fiers T; De Buyzere ML; Delanghe JR
    Clin Chem Lab Med; 2013 Jul; 51(7):1529-34. PubMed ID: 23314557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
    Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
    PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis.
    Middleton A; Binbrek AS; Fonseca FA; Wilpshaar W; Watkins C; Strandberg TE
    Curr Med Res Opin; 2006 Jun; 22(6):1181-91. PubMed ID: 16846551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.
    de Jong HJ; Meyboom RH; Helle MJ; Klungel OH; Niskanen L; Cohen Tervaert JW
    Ann Intern Med; 2014 Oct; 161(8):614-5. PubMed ID: 25329212
    [No Abstract]   [Full Text] [Related]  

  • 36. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
    Bruckert E; Hayem G; Dejager S; Yau C; Bégaud B
    Cardiovasc Drugs Ther; 2005 Dec; 19(6):403-14. PubMed ID: 16453090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.
    Evangelista T; Ferro J; Pereira P; de Carvalho M
    Neuromuscul Disord; 2009 Jan; 19(1):66-8. PubMed ID: 19084404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
    BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.